{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:46:15Z","timestamp":1793727975670,"version":"4.6.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Key R&D Program of China","award":["2018YFC1314700"],"award-info":[{"award-number":["2018YFC1314700"]}]},{"name":"Shanghai Municipal Science and Technology Major Project","award":["No.2018SHZDZX01"],"award-info":[{"award-number":["No.2018SHZDZX01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00415-020-09757-9","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T05:18:19Z","timestamp":1583990299000},"page":"2713-2722","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Predictors of cognitive impairment in Parkinson\u2019s disease: a systematic review and meta-analysis of prospective cohort studies"],"prefix":"10.1007","volume":"268","author":[{"given":"Yu","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-He","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Qiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Peng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Tai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,12]]},"reference":[{"issue":"5","key":"9757_CR1","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/mds.25846","volume":"29","author":"B Mollenhauer","year":"2014","unstructured":"Mollenhauer B, Rochester L, Chen-Plotkin A, Brooks D (2014) What can biomarkers tell us about cognition in Parkinson's disease? Mov Disord 29(5):622\u2013633. https:\/\/doi.org\/10.1002\/mds.25846","journal-title":"Mov Disord"},{"issue":"4","key":"9757_CR2","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/mds.27323","volume":"33","author":"JG Goldman","year":"2018","unstructured":"Goldman JG, Holden SK, Litvan I, McKeith I, Stebbins GT, Taylor JP (2018) Evolution of diagnostic criteria and assessments for Parkinson's disease mild cognitive impairment. Mov Disord 33(4):503\u2013510. https:\/\/doi.org\/10.1002\/mds.27323","journal-title":"Mov Disord"},{"issue":"6","key":"9757_CR3","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1212\/wnl.56.6.730","volume":"56","author":"D Aarsland","year":"2001","unstructured":"Aarsland D, Andersen K, Larsen JP, Lolk A, Nielsen H, Kragh-Sorensen P (2001) Risk of dementia in Parkinson's disease: a community-based, prospective study. Neurology 56(6):730\u2013736. https:\/\/doi.org\/10.1212\/wnl.56.6.730","journal-title":"Neurology"},{"issue":"6","key":"9757_CR4","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 23(6):837\u2013844. https:\/\/doi.org\/10.1002\/mds.21956","journal-title":"Mov Disord"},{"issue":"1","key":"9757_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(16)30328-3","volume":"16","author":"A Schrag","year":"2017","unstructured":"Schrag A, Siddiqui UF, Anastasiou Z, Weintraub D, Schott JM (2017) Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study. Lancet Neurol 16(1):66\u201375. https:\/\/doi.org\/10.1016\/S1474-4422(16)30328-3","journal-title":"Lancet Neurol"},{"issue":"3","key":"9757_CR6","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1136\/jnnp.69.3.308","volume":"69","author":"A Schrag","year":"2000","unstructured":"Schrag A, Jahanshahi M, Quinn N (2000) What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry 69(3):308\u2013312","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"9757_CR7","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1002\/mds.23661","volume":"26","author":"C Vossius","year":"2011","unstructured":"Vossius C, Larsen JP, Janvin C, Aarsland D (2011) The economic impact of cognitive impairment in Parkinson's disease. Mov Disord 26(8):1541\u20131544. https:\/\/doi.org\/10.1002\/mds.23661","journal-title":"Mov Disord"},{"issue":"24","key":"9757_CR8","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa041470","volume":"351","author":"M Emre","year":"2004","unstructured":"Emre M, Aarsland D, Albanese A, Byrne EJ, Deuschl G, De Deyn PP, Durif F, Kulisevsky J, van Laar T, Lees A, Poewe W, Robillard A, Rosa MM, Wolters E, Quarg P, Tekin S, Lane R (2004) Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med 351(24):2509\u20132518. https:\/\/doi.org\/10.1056\/NEJMoa041470","journal-title":"N Engl J Med"},{"issue":"4","key":"9757_CR9","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneurol.2017.27","volume":"13","author":"D Aarsland","year":"2017","unstructured":"Aarsland D, Creese B, Politis M, Chaudhuri KR, Ffytche DH, Weintraub D, Ballard C (2017) Cognitive decline in Parkinson disease. Nat Rev Neurol 13(4):217\u2013231. https:\/\/doi.org\/10.1038\/nrneurol.2017.27","journal-title":"Nat Rev Neurol"},{"issue":"15","key":"9757_CR10","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 283(15):2008\u20132012","journal-title":"JAMA"},{"key":"9757_CR11","doi-asserted-by":"crossref","unstructured":"McInnes MDF, Moher D, Thombs BD, McGrath TA, Bossuyt PM, the P-DTAG, Clifford T, Cohen JF, Deeks JJ, Gatsonis C, Hooft L, Hunt HA, Hyde CJ, Korevaar DA, Leeflang MMG, Macaskill P, Reitsma JB, Rodin R, Rutjes AWS, Salameh JP, Stevens A, Takwoingi Y, Tonelli M, Weeks L, Whiting P, Willis BH (2018) Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement. JAMA 319 (4):388\u2013396. doi: 10.1001\/jama.2017.19163","DOI":"10.1001\/jama.2017.19163"},{"issue":"9","key":"9757_CR12","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A (2010) Critical evaluation of the Newcastle\u2013Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603\u2013605. https:\/\/doi.org\/10.1007\/s10654-010-9491-z","journal-title":"Eur J Epidemiol"},{"issue":"7414","key":"9757_CR13","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557\u2013560. https:\/\/doi.org\/10.1136\/bmj.327.7414.557","journal-title":"BMJ"},{"issue":"11","key":"9757_CR14","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539\u20131558. https:\/\/doi.org\/10.1002\/sim.1186","journal-title":"Stat Med"},{"issue":"7109","key":"9757_CR15","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629\u2013634","journal-title":"BMJ"},{"issue":"2","key":"9757_CR16","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","volume":"56","author":"S Duval","year":"2000","unstructured":"Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56(2):455\u2013463","journal-title":"Biometrics"},{"issue":"5","key":"9757_CR17","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.parkreldis.2015.02.010","volume":"21","author":"CH Lin","year":"2015","unstructured":"Lin CH, Wu RM (2015) Biomarkers of cognitive decline in Parkinson's disease. Parkinsonism Relat Disord 21(5):431\u2013443. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.02.010","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"9757_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S1474-4422(03)00619-7","volume":"3","author":"McKeith I, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, Dickson D, Dubois B, Duda JE, Feldman H, Gauthier S, Halliday G, Lawlor B, Lippa C, Lopez OL, Carlos Machado J, O'Brien J, Playfer J, Reid W, International Psychogeriatric Association Expert Meeting on DLB","year":"2004","unstructured":"McKeith I, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, Dickson D, Dubois B, Duda JE, Feldman H, Gauthier S, Halliday G, Lawlor B, Lippa C, Lopez OL, Carlos Machado J, O'Brien J, Playfer J, Reid W, International Psychogeriatric Association Expert Meeting on DLB (2004) Dementia with Lewy bodies. Lancet Neurol 3(1):19\u201328","journal-title":"Lancet Neurol"},{"issue":"7","key":"9757_CR19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira AHV, Chaudhuri KR, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev Neurosci 18(7):435\u2013450. https:\/\/doi.org\/10.1038\/nrn.2017.62","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"9757_CR20","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/mds.25389","volume":"28","author":"K Zhu","year":"2013","unstructured":"Zhu K, van Hilten JJ, Putter H, Marinus J (2013) Risk factors for hallucinations in Parkinson's disease: results from a large prospective cohort study. Mov Disord 28(6):755\u2013762. https:\/\/doi.org\/10.1002\/mds.25389","journal-title":"Mov Disord"},{"issue":"5","key":"9757_CR21","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1136\/jnnp.2005.081711","volume":"77","author":"DJ Burn","year":"2006","unstructured":"Burn DJ, Rowan EN, Allan LM, Molloy S, O'Brien JT, McKeith IG (2006) Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 77(5):585\u2013589. https:\/\/doi.org\/10.1136\/jnnp.2005.081711","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"9757_CR22","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1001\/archneurol.2008.596","volume":"66","author":"T Tapiola","year":"2009","unstructured":"Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, Pirttila T (2009) Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch Neurol 66(3):382\u2013389. https:\/\/doi.org\/10.1001\/archneurol.2008.596","journal-title":"Arch Neurol"},{"issue":"10","key":"9757_CR23","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1212\/WNL.54.10.1916","volume":"54","author":"HI Hurtig","year":"2000","unstructured":"Hurtig HI, Trojanowski JQ, Galvin J, Ewbank D, Schmidt ML, Lee VM, Clark CM, Glosser G, Stern MB, Gollomp SM, Arnold SE (2000) Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology 54(10):1916\u20131921","journal-title":"Neurology"},{"issue":"Pt 6","key":"9757_CR24","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1093\/brain\/awf134","volume":"125","author":"K Ito","year":"2002","unstructured":"Ito K, Nagano-Saito A, Kato T, Arahata Y, Nakamura A, Kawasumi Y, Hatano K, Abe Y, Yamada T, Kachi T, Brooks DJ (2002) Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: a 6-[18F]fluoro-L-dopa PET study. Brain 125(Pt 6):1358\u20131365","journal-title":"Brain"},{"issue":"3","key":"9757_CR25","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s004019900168","volume":"100","author":"PM Mattila","year":"2000","unstructured":"Mattila PM, Rinne JO, Helenius H, Dickson DW, Roytta M (2000) Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease. Acta Neuropathol 100(3):285\u2013290","journal-title":"Acta Neuropathol"},{"issue":"2","key":"9757_CR26","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1001\/jamaneurol.2017.3713","volume":"75","author":"JR Winer","year":"2018","unstructured":"Winer JR, Maass A, Pressman P, Stiver J, Schonhaut DR, Baker SL, Kramer J, Rabinovici GD, Jagust WJ (2018) Associations between tau, beta-amyloid, and cognition in parkinson disease. JAMA Neurol 75(2):227\u2013235. https:\/\/doi.org\/10.1001\/jamaneurol.2017.3713","journal-title":"JAMA Neurol"},{"key":"9757_CR27","doi-asserted-by":"crossref","unstructured":"Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278 (16):1349\u20131356","DOI":"10.1001\/jama.278.16.1349"},{"issue":"3","key":"9757_CR28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00415-009-0119-8","volume":"256","author":"CH Williams-Gray","year":"2009","unstructured":"Williams-Gray CH, Goris A, Saiki M, Foltynie T, Compston DA, Sawcer SJ, Barker RA (2009) Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease. J Neurol 256(3):493\u2013498. https:\/\/doi.org\/10.1007\/s00415-009-0119-8","journal-title":"J Neurol"},{"issue":"8","key":"9757_CR29","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S1474-4422(12)70152-7","volume":"11","author":"P Svenningsson","year":"2012","unstructured":"Svenningsson P, Westman E, Ballard C, Aarsland D (2012) Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment. Lancet Neurol 11(8):697\u2013707. https:\/\/doi.org\/10.1016\/S1474-4422(12)70152-7","journal-title":"Lancet Neurol"},{"issue":"8","key":"9757_CR30","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S1474-4422(17)30122-9","volume":"16","author":"G Liu","year":"2017","unstructured":"Liu G, Locascio JJ, Corvol JC, Boot B, Liao Z, Page K, Franco D, Burke K, Jansen IE, Trisini-Lipsanopoulos A, Winder-Rhodes S, Tanner CM, Lang AE, Eberly S, Elbaz A, Brice A, Mangone G, Ravina B, Shoulson I, Cormier-Dequaire F, Heutink P, van Hilten JJ, Barker RA, Williams-Gray CH, Marinus J, Scherzer CR (2017) Hbs, CamPaIgn, Picnics, Propark, Psg, Digpd, Pdbp. Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts. Lancet Neurol 16(8):620\u2013629. https:\/\/doi.org\/10.1016\/S1474-4422(17)30122-9","journal-title":"Lancet Neurol"},{"issue":"1","key":"9757_CR31","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/brain\/awx310","volume":"141","author":"NJ Ray","year":"2018","unstructured":"Ray NJ, Bradburn S, Murgatroyd C, Toseeb U, Mir P, Kountouriotis GK, Teipel SJ, Grothe MJ (2018) In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease. Brain 141(1):165\u2013176. https:\/\/doi.org\/10.1093\/brain\/awx310","journal-title":"Brain"},{"issue":"5","key":"9757_CR32","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1093\/brain\/awy072","volume":"141","author":"J Schulz","year":"2018","unstructured":"Schulz J, Pagano G, Fernandez Bonfante JA, Wilson H, Politis M (2018) Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson's disease. Brain J Neurol 141(5):1501\u20131516. https:\/\/doi.org\/10.1093\/brain\/awy072","journal-title":"Brain J Neurol"},{"issue":"4","key":"9757_CR33","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/mds.25352","volume":"28","author":"GW Duncan","year":"2013","unstructured":"Duncan GW, Firbank MJ, O'Brien JT, Burn DJ (2013) Magnetic resonance imaging: a biomarker for cognitive impairment in Parkinson's disease? Mov Disord 28(4):425\u2013438. https:\/\/doi.org\/10.1002\/mds.25352","journal-title":"Mov Disord"},{"issue":"Pt 1","key":"9757_CR34","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/brain\/awr277","volume":"135","author":"D Weintraub","year":"2012","unstructured":"Weintraub D, Dietz N, Duda JE, Wolk DA, Doshi J, Xie SX, Davatzikos C, Clark CM, Siderowf A (2012) Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease. Brain 135(Pt 1):170\u2013180. https:\/\/doi.org\/10.1093\/brain\/awr277","journal-title":"Brain"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-09757-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-020-09757-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-09757-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T12:04:58Z","timestamp":1626696298000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-020-09757-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,12]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["9757"],"URL":"https:\/\/doi.org\/10.1007\/s00415-020-09757-9","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,12]]},"assertion":[{"value":"20 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None authors have financial disclosures and conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The manuscript does not contain clinical studies or patient data. No additional ethics approval was required for this systematic review and meta-analysis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}